When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CorMedix (NASDAQ:CRMD) announces changes to its executive leadership team with Khoso Baluch retiring from his role as CEO, effective October 4, 2021, and has also resigned from the Company’s Board of Directors. John Armstrong, EVP for Technical Operations, is retiring from CorMedix, effective same date. The Board has appointed Matt David, M.D., EVP and CFO, as interim CEO, effective immediately. Dr. David will continue to hold his position of CFO. The Board has initiated a search process for a permanent CEO.